Low-field portable brain MRI systems lead the market with a 37.3% share in 2026, followed by hospitals at 37.3% by end user and stroke diagnosis at 34.1% by application. Adoption reflects demand for rapid bedside neuroimaging, while image quality limitations and reimbursement challenges remain key constraints.